38 related articles for article (PubMed ID: 35995702)
1. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
[No Abstract] [Full Text] [Related]
2. Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma.
Gu S; Wang X; Zhou J; Du S; Niu T
Front Oncol; 2024; 14():1373127. PubMed ID: 38655138
[TBL] [Abstract][Full Text] [Related]
3. Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review.
Iturrate I; Loscertales J; Fernández-Ruiz E; Muñoz P; López C; Del Campo L; Muñoz C; Alegre A
Clin Case Rep; 2020 Dec; 8(12):3494-3497. PubMed ID: 33363958
[TBL] [Abstract][Full Text] [Related]
4. Biological insights into the role of TET2 in T cell lymphomas.
Carty SA
Front Oncol; 2023; 13():1199108. PubMed ID: 37841428
[TBL] [Abstract][Full Text] [Related]
5. Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability.
Zain J; Kallam A
Front Oncol; 2023; 13():1150715. PubMed ID: 37188189
[TBL] [Abstract][Full Text] [Related]
6. Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.
Kalac M; Jain S; Tam CS; Xiao Z; Montanari F; Kanakry J; Huber BD; Goldfinger M; O'Connor OA; Marchi E
Blood Adv; 2023 Jul; 7(14):3760-3763. PubMed ID: 36790924
[No Abstract] [Full Text] [Related]
7. Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma.
Yap DRY; Lim JQ; Huang D; Ong CK; Chan JY
Front Immunol; 2023; 14():1068662. PubMed ID: 36776886
[TBL] [Abstract][Full Text] [Related]
8. Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.
Wang Y; Xie B; Chen Y; Huang Z; Tan H
Int J Clin Exp Pathol; 2014; 7(6):3432-8. PubMed ID: 25031772
[TBL] [Abstract][Full Text] [Related]
9. Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma.
Yoon SE; Cho J; Kim YJ; Kim SJ; Kim WS
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):e972-e980. PubMed ID: 35995702
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
[TBL] [Abstract][Full Text] [Related]
11. DNMT3A
Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
[TBL] [Abstract][Full Text] [Related]
12. Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
Saillard C; Guermouche H; Derrieux C; Bruneau J; Frenzel L; Couronne L; Asnafi V; Macintyre E; Trinquand A; Lhermitte L; Molina T; Suarez F; Lemonnier F; Kosmider O; Delarue R; Hermine O; Cheminant M
Hematol Oncol; 2017 Dec; 35(4):864-868. PubMed ID: 27353473
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
Tari G; Lemonnier F; Morschhauser F
Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
[TBL] [Abstract][Full Text] [Related]
14. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A
Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
